To evade cell cycle controls, malignant cells rely upon rapid expression of select proteins to mitigate pro-apoptotic signals resulting from damage caused by both cancer treatments and unchecked over-proliferation. Cyclin-dependent ...
Dec 29, 2023
0
20
Brain and other central nervous system (CNS) cancers are the leading cause of childhood cancer deaths in the United States. This type of cancer is the second most common type of childhood cancer after leukemia.
Dec 29, 2023
0
0
Scientists have found an experimental small molecule that induces a form of cell death to kill a variety of cancers while enhancing the power of the immune system and leaving healthy cells totally unscathed.
Researchers at Huntsman Cancer Institute at the University of Utah discovered that the level of blood and immune cells in mouse model offspring would fluctuate based on the amount of folic acid consumed by their mothers during ...
Dec 14, 2023
0
0
The advent of T-cell therapies, where cells of the immune system are directed towards malignant cells, has changed the treatment paradigm of certain forms of blood cancer. However, despite the huge progress in this field, ...
Dec 13, 2023
0
2
New research at ACR Convergence 2023, the American College of Rheumatology's annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining ...
Nov 7, 2023
0
1
The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of ...
Oct 17, 2023
0
22
A team of biomedical engineers from Brown University has developed a new hydrogel-based delivery system that balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of the chemotherapeutic ...
Sep 20, 2023
0
42
Cancer patients appeared to benefit from natural killer cells obtained from donors in an experimental method of treating cancer that involved an aggressive army of immune system fighters endowed with the ability to home in ...
Researchers at the University of Arizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The results of the study were published ...
Sep 11, 2023
0
50
